The U.S. remains one of the most competitive and tightly regulated markets for medical devices. But even with a high-quality product, many companies face costly delays—not because of flaws in the technology, but due to gaps in documentation or misunderstanding of regulatory requirements.
When preparing a medical device for the U.S. market, the Instructions for Use (IFU) is not just a user manual—it’s a regulatory document subject to FDA scrutiny. A compliant IFU must clearly communicate safe and proper product use while meeting both FDA requirements and international standards. To support this critical task, Hansem Global and Amin Wasserman Gurnani (AWG) offer a […]
Regulatory Group Co-Chairs Rend Al-Mondhiry and Bob Durkin explore the regulatory hurdles surrounding the marketing of novel ingredients in dietary supplements in an article published by SupplySide Supplement Journal.
In our latest “AWG Legal Takeaways” column, published by SupplySide Supplement Journal, Rend Al-Mondhiry examines growing attacks against hemp products by the states and the counteroffensives by industry in the courts.
In a Legal Backgrounder published by Washington Legal Foundation on July 8, 2024, Jennifer Adams writes: “False advertising challenges to “all natural” and similar “natural” claims have been among the most prolific litigation trends for consumer product companies. Currently, there is no legal or regulatory definition of “natural,” and cases have either settled before reaching […]
Litigators William Cole and Matthew Orr discuss the business of plum financial paydays for plaintiffs’ lawyers and strategies for defending against frivolous, baseless, pursued-in-bad-faith claims in the current issue of Nutrition Industry Executive/VRM Media.
In his article, “Before, During, and After FDA Inspections,” published by the American Health Law Association, Evan Phelps highlights practical tips and best practices for regulated facilities to prepare for inspections.
In the last of our three-part series in Natural Products Insider highlighting legal issues and bottom-line challenges that impact consumer-facing companies, Rend Al-Mondhiry explains that states are taking the lead in regulating consumer products and their ingredients—requiring increased monitoring—and the FDA is prioritizing its own list for review.
Los Angeles, CA, July 14, 2025–Amin Wasserman Gurnani (AWG) is pleased to announce the addition of partners Rebecca Lee and Jennifer Singh to the firm’s Litigation and Prop 65 practice groups, expanding its team of MORE >
see all news >